FOLD logo
FOLD

Amicus Therapeutics Inc

Biotechnology

Amicus Therapeutics Inc (FOLD) Earnings

Last reported
May 13, 2026
EPS estimate
$0.03
EPS actual
Revenue est.
$165.3M
Revenue actual